BioBridgeXAll companies

CareDx, Inc.

Laboratory testing company · Brisbane, California, United States · Nasdaq: CDNA

CareDx, Inc. is a laboratory testing company headquartered in Brisbane, California, United States. Its shares trade on Nasdaq under the ticker CDNA. The US FDA lists 1 medical device site registered to the company, with devices in cardiovascular, anesthesiology and pathology. It has reported private securities offerings to the US SEC, most recently $22 million sold in a notice filed in 2016.

Profile compiled from public records. Is this your company? Request a correction or update

CareDx at a glance

Typelaboratory testing company
HeadquartersBrisbane, California, United States
Stock listingNasdaq: CDNA
SEC industryServices-Medical Laboratories
FDA-registered sites1
SEC CIK1217234

What does CareDx do?

Medical specialties of its FDA-listed devices

CardiovascularAnesthesiologyPathology

Device types listed with the FDA

Cardiac allograft gene expression profiling test systemBlood specimen collection kit (excludes hiv testing)General purpose reagent

Private fundraising reported to the SEC

4 Form D notices; the most recent reported $22.2 million sold (2016).

Where is CareDx located?

Headquarters: Brisbane, California, United States

  • Brisbane, CaliforniaCareDx, Inc. · FDA device site

Frequently asked questions about CareDx

Where is CareDx headquartered?

CareDx, Inc. is headquartered in Brisbane, California, United States.

What does CareDx do?

CareDx, Inc. is a laboratory testing company. Its FDA-listed medical devices fall under cardiovascular, anesthesiology and pathology. Its SEC industry classification is Services-Medical Laboratories.

Is CareDx a public company?

Yes. CareDx, Inc. trades on Nasdaq under the ticker CDNA.

Similar companies

Work with CROs and CDMOs like CareDx

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

List your services on BioBridgeX

Last updated 2026-09-24. Data licences